Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.5592 per EA under NDC 68462040560. Its NADAC has been published 333 times since Apr 8, 2020.
FDA first approved this application on May 24, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 200 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462040560
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA210318FDA Approved
5/24/2019
TE Code
AB
On Market Since
5/24/2019
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 333 times since Apr 8, 2020, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5592 per EA |
|---|---|
| All-time high | $2.3958 (Apr 15, 2020) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.7574 |
| Average price | $0.8750 |
| Largest weekly change | +44.2% (Apr 21, 2021) |
| Weeks tracked | 333 |
| Tracking since | Apr 8, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.5592 per EA (NDC 68462040560), effective Aug 19, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 76.7%. It has been tracked across 333 weekly CMS publications since Apr 8, 2020.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Apr 8, 2020, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $2.3958 (Apr 15, 2020), with a median of $0.7574 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
No other NADAC-published product currently shares the active ingredient and strength of ASPIRIN-DIPYRIDAM ER 25-200 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 68462040560) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.